A Study of Insulin Glargine (LY2963016) in Healthy Chinese Participants

NCT03555305 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

58

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Insulin Glargine
DRUG: Lantus

Sponsor

Eli Lilly and Company